Invention Grant
US08722632B2 Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule
有权
通过施用可溶性CTLA4分子治疗干燥综合征的方法
- Patent Title: Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule
- Patent Title (中): 通过施用可溶性CTLA4分子治疗干燥综合征的方法
-
Application No.: US13788970Application Date: 2013-03-07
-
Publication No.: US08722632B2Publication Date: 2014-05-13
- Inventor: Robert Cohen , Suzette Belder-Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Nickki L. Parlet
- Main IPC: A61K38/16
- IPC: A61K38/16
Abstract:
The present invention relates to compositions and methods for treating autoimmune diseases, such as Sjogren's syndrome, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Public/Granted literature
- US20130230518A1 METHODS FOR TREATING SJOGRENS SYNDROME BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE Public/Granted day:2013-09-05
Information query
IPC分类:
